Page last updated: 2024-11-04

sulforaphane and Progeria

sulforaphane has been researched along with Progeria in 1 studies

sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.

Progeria: An abnormal congenital condition, associated with defects in the LAMIN TYPE A gene, which is characterized by premature aging in children, where all the changes of cell senescence occur. It is manifested by premature graying; hair loss; hearing loss (DEAFNESS); cataracts (CATARACT); ARTHRITIS; OSTEOPOROSIS; DIABETES MELLITUS; atrophy of subcutaneous fat; skeletal hypoplasia; elevated urinary HYALURONIC ACID; and accelerated ATHEROSCLEROSIS. Many affected individuals develop malignant tumors, especially SARCOMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gabriel, D1
Roedl, D1
Gordon, LB1
Djabali, K1

Other Studies

1 other study available for sulforaphane and Progeria

ArticleYear
Sulforaphane enhances progerin clearance in Hutchinson-Gilford progeria fibroblasts.
    Aging cell, 2015, Volume: 14, Issue:1

    Topics: Cell Line; Cell Nucleus; DNA Damage; Drug Synergism; Electrophoresis, Gel, Two-Dimensional; Enzyme I

2015